Jim Simons's position in Cytokinetics is currently worth $6.24 Million. That's 0.01% of their equity portfolio (1181st largest holding). The first Cytokinetics trade was made in Q4 2013. Since then Jim Simons bought shares seventeen more times and sold shares on eleven occasions. The investor's estimated purchase price is $13.5 Million, resulting in a loss of 54%.